Current Context: The Department of Biotechnology (DBT), through its Grand Challenges India (GCI) initiative at Biotechnology Industry Research Assistance Council (BIRAC), announced the successful scientific review and validation of India’s first indigenously developed Human Papillomavirus (HPV) test kits for cervical cancer screening.

About

• Developed by Molbio Diagnostics Ltd., Bangalore and Mylab Discovery Solutions Pvt. Ltd., Pune.
• Validation supported by World Health Organization (WHO)’sInternational Agency for Research on Cancer (IARC).
• Aims to strengthen cervical cancer diagnostics through affordable, indigenous solutions.
• Part of efforts to promote healthcare innovation under the biotechnology sector.